Skip to main content
Top
Published in: Clinical Rheumatology 12/2012

01-12-2012 | Original Article

Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China

Authors: Hui Lin, James Cheng-Chung Wei, Chun-yu Tan, Yuan-yuan Liu, Yan-hong Li, Feng-xia Li, Dai-hua Deng, Bing Yan, Yi Liu, Yi Zhao

Published in: Clinical Rheumatology | Issue 12/2012

Login to get access

Abstract

The aim of this study is to explore the survival rate and risk factors of mortality in patients with late-onset systemic lupus erythematosus (SLE) in a large cohort. Clinical presentations, disease activity, organ damage scores, autoantibody profile, and mortality data were obtained retrospectively from late-onset SLE patients (onset age ≥50 years) diagnosed between 1995 and 2009. The risk factors of organ damage were evaluated by the chi-square test and logistic regression. The cumulative rate of survival was calculated by Kaplan–Meier method, and factors predictive of mortality were studied by Cox proportion hazard regression model. A total of 158 patients (132 female and 26 male) were studied. The average onset age was 58.66 ± 6.38 years and mean disease duration was 63.85 ± 48.17 months. One hundred and four patients had organ damage at the time of data analysis. Hematological system and kidney involvement were most common. Central nervous system involvement was relatively rare. In univariate logistic analysis, associations were found between SLE disease activity index (SLEDAI) at diagnosis (OR = 1.133, P = 0.001); renal involvement (OR = 2.441, P = 0.009) and edema (OR = 2.812, P = 0.003) were associated with organ damage. And SLEDAI at diagnosis (OR = 1.103, P = 0.034) was independent factor for organ damage in multivariate logistic regression. During the follow-up, 64 patients (51 female and 13 male) died. Five-, 10-, and 15-year survival rates were 80.4, 56.5, and 31.7 %, respectively. Median survival time was 123 months. The analysis of Cox proportion hazard regression model showed that age at disease onset (OR = 1.069, P = 0.002), compliance of medical care (OR = 3.282, P = 0.001), and SLEDAI at diagnosis (OR = 1.091, P = 0.003) were independent risk factors of mortality. Late-onset SLE has a poor long-term prognosis. Infection is the major cause of death in patients with late-onset lupus. Disease activity, medical care, and onset age are strongly related to death of late-onset SLE.
Literature
1.
go back to reference Ho CT, Mok CC, Lau CS, Wong RW (1998) Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 57:437–440PubMedCrossRef Ho CT, Mok CC, Lau CS, Wong RW (1998) Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 57:437–440PubMedCrossRef
2.
go back to reference Costallat LT, Coimbra AM (1994) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12:603–607PubMed Costallat LT, Coimbra AM (1994) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12:603–607PubMed
3.
go back to reference Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC (2004) Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 83:348–359PubMedCrossRef Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC (2004) Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 83:348–359PubMedCrossRef
4.
go back to reference Bertoli AM, Alarcón GS, Calvo-Alén J, Fernández M, Vilá LM, Reveille JD, Study Group LUMINA (2006) Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical (corrected) features, course and outcome in patients with late-onset disease. Arthritis Rheum 54:1580–1587PubMedCrossRef Bertoli AM, Alarcón GS, Calvo-Alén J, Fernández M, Vilá LM, Reveille JD, Study Group LUMINA (2006) Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical (corrected) features, course and outcome in patients with late-onset disease. Arthritis Rheum 54:1580–1587PubMedCrossRef
5.
go back to reference Maddison P, Farewell V, Isenberg D et al (2002) The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29:913–917PubMed Maddison P, Farewell V, Isenberg D et al (2002) The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29:913–917PubMed
6.
go back to reference Lalani S, Pope J, de Leon F, Peschken C, Members of CaNIOS/1000 Faces of Lupus (2010) Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 Faces of Lupus study. J Rheumatol 37:38–44PubMedCrossRef Lalani S, Pope J, de Leon F, Peschken C, Members of CaNIOS/1000 Faces of Lupus (2010) Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 Faces of Lupus study. J Rheumatol 37:38–44PubMedCrossRef
7.
go back to reference Ward MM, Polisson RP (1989) A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum 32:1226–1232PubMedCrossRef Ward MM, Polisson RP (1989) A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum 32:1226–1232PubMedCrossRef
8.
go back to reference Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Med (Baltimore) 85:147–156CrossRef Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Med (Baltimore) 85:147–156CrossRef
9.
go back to reference Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Med (Baltimore) 82:299–308CrossRef Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Med (Baltimore) 82:299–308CrossRef
10.
go back to reference Blanco FJ, Gómez-Reino JJ, de la Mata J et al (1998) Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 7:159–163PubMedCrossRef Blanco FJ, Gómez-Reino JJ, de la Mata J et al (1998) Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 7:159–163PubMedCrossRef
11.
go back to reference Contreras G, Lenz O, Pardo V et al (2006) Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 69:1846–1851PubMedCrossRef Contreras G, Lenz O, Pardo V et al (2006) Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 69:1846–1851PubMedCrossRef
12.
go back to reference Rabbani MA, Habib HB, Islam M et al (2009) Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 18:848–855PubMedCrossRef Rabbani MA, Habib HB, Islam M et al (2009) Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 18:848–855PubMedCrossRef
13.
go back to reference Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
14.
go back to reference Gladman DD, Goldsmith CH, Urowitz MB et al (1994) Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 21:1468–1471PubMed Gladman DD, Goldsmith CH, Urowitz MB et al (1994) Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 21:1468–1471PubMed
15.
go back to reference Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369PubMedCrossRef Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369PubMedCrossRef
16.
go back to reference Appenzeller S, Pereira DA, Costallat LT (2008) Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Lupus 17:1023–1028PubMedCrossRef Appenzeller S, Pereira DA, Costallat LT (2008) Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Lupus 17:1023–1028PubMedCrossRef
17.
go back to reference Koh ET, Boey ML (1994) Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 21:1463–1467PubMed Koh ET, Boey ML (1994) Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 21:1463–1467PubMed
18.
go back to reference Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Med (Baltimore) 84:218–224CrossRef Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Med (Baltimore) 84:218–224CrossRef
19.
go back to reference Zonana-Nacach A, Yañez P, Jiménez-Balderas FJ, Camargo-Coronel A (2007) Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Lupus 6:997–1000CrossRef Zonana-Nacach A, Yañez P, Jiménez-Balderas FJ, Camargo-Coronel A (2007) Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Lupus 6:997–1000CrossRef
20.
go back to reference Nossent J, Cikes N, Kiss E et al (2007) Current causes of death in systemic lupus erythematosus in Europe, 2000–2004: relation to disease activity and damage accrual. Lupus 16:309–317PubMedCrossRef Nossent J, Cikes N, Kiss E et al (2007) Current causes of death in systemic lupus erythematosus in Europe, 2000–2004: relation to disease activity and damage accrual. Lupus 16:309–317PubMedCrossRef
21.
go back to reference Cook RJ, Gladman DD, Pericak D, Urowitz MB (2000) Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 27:1892–1895PubMed Cook RJ, Gladman DD, Pericak D, Urowitz MB (2000) Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 27:1892–1895PubMed
22.
go back to reference Rovenský J, Tuchynová A (2008) Systemic lupus erythematosus in the elderly. Autoimmun Rev 7:235–239PubMedCrossRef Rovenský J, Tuchynová A (2008) Systemic lupus erythematosus in the elderly. Autoimmun Rev 7:235–239PubMedCrossRef
23.
go back to reference Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9:96–100PubMedCrossRef Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9:96–100PubMedCrossRef
24.
go back to reference Lazaro D (2007) Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment. Drugs Aging 24:701–715PubMedCrossRef Lazaro D (2007) Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment. Drugs Aging 24:701–715PubMedCrossRef
25.
go back to reference Ward MM, Pyun E, Studenski S (1996) Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 156:1337–1344PubMedCrossRef Ward MM, Pyun E, Studenski S (1996) Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 156:1337–1344PubMedCrossRef
26.
go back to reference Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 22:1265–1270PubMed Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 22:1265–1270PubMed
27.
go back to reference Ward MM, Pyun E, Studenski S (1995) Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 38:274–283PubMedCrossRef Ward MM, Pyun E, Studenski S (1995) Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 38:274–283PubMedCrossRef
28.
go back to reference Gladman DD (1996) Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 8:430–437PubMedCrossRef Gladman DD (1996) Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 8:430–437PubMedCrossRef
29.
go back to reference Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (2002) Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46:436–444PubMedCrossRef Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (2002) Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46:436–444PubMedCrossRef
30.
go back to reference Zonana-Nacach A, Barr SG, Magder LS, Petri M (2000) Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43:1801–1808PubMedCrossRef Zonana-Nacach A, Barr SG, Magder LS, Petri M (2000) Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43:1801–1808PubMedCrossRef
Metadata
Title
Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China
Authors
Hui Lin
James Cheng-Chung Wei
Chun-yu Tan
Yuan-yuan Liu
Yan-hong Li
Feng-xia Li
Dai-hua Deng
Bing Yan
Yi Liu
Yi Zhao
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 12/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-2073-6

Other articles of this Issue 12/2012

Clinical Rheumatology 12/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.